Abstract
Apomorphine, d-amphetamine, methylphenidate, nomifensine, ET495 and amantadine each induced a dose-dependent stereotyped behaviour in the rat. l-Dopa was inactive in the absence of any pretreatment. The behaviour induced by apomorphine, methylphenidate, nomifensine and amantadine persisted following pretreatment with α-methylparatyrosine. However, only the effect of apomorphine developed following combined pretreatment with reserpine/ α-methylparatyrosine. The effects of all Stereotypic agents were inhibited by haloperidol, apomorphine, methylphenidate and nomifensine being most resistant.
All agents, including l-Dopa, induced a dose-dependent contralateral circling behaviour in animals with asymmetric lesion of the medial raphé nucleus and a dose-dependent ipsilateral circling after unilateral lesion of the substantia nigra. Following unilateral lesions in the ventromedial area of the medial forebrain bundle (medial to the substantia nigra and carrying 5-hydroxytryptamine neurones) amphetamine caused an ipsilateral circling behaviour, amantadine a behaviour which was characterised by definite bursts in either direction, and all other agents caused contralateral circling.
Similar content being viewed by others
References
Agid, Y., Javoy, F., Glowinski, J., Bouvet, D., Sotelo, C.: Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity. Brain Res. 58, 291–302 (1973)
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K.: Functional role of the nigro-neostriatal dopamine neurons. Acta pharmacol. (Kbh.) 24, 263–274 (1966)
Broch, D. J., Marsden, C. A.: Regional distribution of monoamines in the corpus striatum of the rat. Brain Res. 38, 425–428 (1972)
Costall, B., Naylor, R.J.: The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 117–133 (1973)
Costall, B., Naylor, R. J.: Stereotyped and circling behaviour induced by dopamine-like agents after lesions of the midbrain raphé nuclei. Europ. J. Pharmacol. (in press) (1974)
Costall, B., Naylor, R. J., Olley, J. E.: Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacol. 11, 645–663 (1972)
Costall, B., Naylor, R. J., Pinder, R. M.: Design of agents for stimulation of neostriatal dopaminergic mechanisms. J. Pharm. Pharmacol. (in press) (1974)
De Groot, J.: The rat brain in stereotaxic coordinates. Verh. K. Ned. Akad. Wet. 52, 14–39 (1959)
Faull, R. L. M., Laverty, R.: Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. Exp. Neurol. 23, 332–340 (1969)
Fuxe, K.: Evidence for the existance of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta physiol. scand., Suppl. 247, 37–84 (1965)
Fuxe, K.: Tools in the treatment of Parkinson's disease: studies on new types of dopamine receptor stimulating agents. In: Progress in the treatment of Parkinsonism. Adv. Neurol., Calne, D.B., ed., Vol. 3, pp. 273–280. New York: Raven Press 1973
Fuxe, K., Corrodi, H., Hökfelt, T., Lidbrink, P., Ungerstedt, U.: Ergocornine and 2-Br-α-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med. Biol. (in press) (1974)
Fuxe, K., Ungerstedt, U.: Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration. In: International symposium on amphetamines and related compounds. Costa, E., and Garattini, S., eds., pp. 257–288. New York: Raven Press 1970
Hassler, R., Bak, J. J.: Unbalanced ratios of striatal dopamine and serotonin after experimental interruption of strionigral connections in rat. In: Third symposium on Parkinson's disease. Gillingham, F.J., and Donaldson, I. M. L., eds., pp. 29–37. Edinburgh: Livingstone 1968
Hökfelt, T., Ungerstedt, U.: Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. Brain Res. 60, 269–297 (1973)
Hornykiewicz, O.: Parkinson's disease: from brain homogenates to treatment. Fed. Proc. 32, 183–190 (1973)
Keller, H. H., Bartholini, G., Pletscher, A.: Drug-induced changes of striatal cholinergic and dopaminergic functions in rats with spreading depression. J. Pharm. Pharmacol. 25, 433–436 (1973)
König, J. F. R., Klippel, R. A.: The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: The Williams and Wilkins Comp. 1963
Kostowski, W., Giacalone, E., Garattini, S., Valzelli, L.: Studies on behavioural and biochemical changes in rats after lesion of midbrain raphé. Europ. J. Pharmacol. 4, 371–376 (1968)
Kuhar, M. J., Roth, R. H., Aghajanian, G. K.: Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphé lesions. Brain Res. 35, 167–176 (1971)
Kuhar, M. J., Roth, R. H., Aghajanian, G. K.: Synaptosomes from forebrains of rats with midbrain raphé lesions: selective reduction of serotonin uptake. J. Pharmacol. exp. Ther. 181, 36–45 (1972a)
Kuhar, M. J., Roth, R. H., Aghajanian, G. K.: Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphé lesions: correlations with serotonin levels and histochemical fluorescence. Brain Res. 44, 165–176 (1972b)
Malseed, R.T., Baker, W. W.: Analysis of tremorogenic effects of intracaudate serotonin. Proc. Soc. exp. Biol. (N.Y.) 143, 1088–1097 (1973)
Ungerstedt, U.: 6-hydroxydopamine induced degeneration of central monoamine neurons. Europ. J. Pharmacol. 5, 107–110 (1968)
Ungerstedt, U.: Stereotaxic mapping of the monoamine pathways in the rat brain. Acta physiol. scand., Suppl. 367, 1–48 (1971a)
Ungerstedt, U.: Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta physiol. scand., Suppl. 367, 49–68 (1971b)
Ungerstedt, U.: Postsynaptic sypersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta physiol. scand., Suppl. 367, 69–93 (1971c)
Ungerstedt, U., Avemo, A., Avemo, E., Ljungberg, T., Ranje, C.: Animal models of parkinsonism. In: Progress in the treatment of parkinsonism. Adv. Neurol., Calne, D. B., ed., Vol. 3, pp. 257–271. New York: Raven Press 1973
Ungerstedt, U., Butcher, L. L., Butcher, S. G., Andén, N.-E., Fuxe, K.: Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 14, 461–471 (1969)
Von Voigtlander, P. F., Moore, K. E.: Turning behaviour of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, l-Dopa, amantadine, amphetamine and other psychomotor stimulants. Neuropharmacol. 12, 451–462 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Costall, B., Naylor, R.J. A comparison of circling models for the detection of antiparkinson activity. Psychopharmacologia 41, 57–64 (1975). https://doi.org/10.1007/BF00421307
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00421307